A national strategy for the elimination of hepatitis B and C [electronic resource] : phase two report / Gillian J. Buckly and Brian L. Strom, editors ; Committee on a National Strategy for the Elimination of Hepatitis B and C, Board on Population Health and Public Health Practice, Health and Medicine Divsion ; a report of the National Academies of Sciences, Engineering, Medicine
- Washington, DC : National Academies Press, 2017.
- Physical Description:
- xvi, 280 pages : illustrations (some color) ; 23 cm.
- Additional Creators:
- Buckley, Gillian J., Strom, Brian L., and National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on a National Strategy for the Elimination of Hepatitis B and C.
- Restrictions on Access:
- License restrictions may limit access.
- Introduction -- Targets for elimination -- Public health information -- Essential interventions -- Service delivery -- Financing elimination -- Research -- Appendix A: Population health impact and cost-effectiveness of chronic hepatitis B diagnosis, care, and treatment in the United States -- Appendix B: Modeling the elimination of hepatitis C in the United States -- Appendix C: Public meeting agenda -- Appendix D: Committee biographies.
- "Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them"--
- 9780309457293 (pbk)
- Bibliography Note:
- Includes bibliographical references/
- Funding Information:
- "This activity was supported by the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America, the National Viral Hepatitis Roundtable, and the U.S. Department of Health and Human Services/Centers for Disease Control and Prevention (Contract No. 200-2011-38807, Task Order #44. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project"--Title page verso.
View MARC record | catkey: 22597100